Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; this is a minor version label and does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor versioning change that does not affect study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the site footer; this is a minor maintenance update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedLocation information was updated: state locations (California, Massachusetts, Missouri, New York, Texas) were revised under Locations and the revision tag updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.6%

- Check91 days agoChange DetectedMinor editorial updates to the Publications section text and the revision label (v3.2.0 to v3.3.2) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe funding-lapse notice has been removed from the page, and other study content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.